|
Cocoa catabolites |
31/08/2021 |
kmunoz |
|
Effect of the prebiotic OCEAN ACTIVES® Fucoidan in promoting a healthy intestinal microbiome |
31/05/2024 |
HHA |
|
NUTRIRES2 |
31/03/2022 |
SSA |
|
D004 vs terazosin |
30/09/2016 |
CPN |
|
Itolizumab-Plasmapheresis in patients with COVID-19 |
30/06/2021 |
CIM |
|
Policosanol in patients with pre-hypertension or with grade I hypertension |
30/06/2021 |
CPN |
|
Anti SARS-CoV-2 gammaglobulin |
30/06/2021 |
AICA |
|
Policosanol + aspirin in post-stroke cognitive impairment |
30/06/2021 |
CPN |
|
Effect and Safety of the nebulized surfactant SURFACEN® in the treatment of broncho-obstructive syndrome in children. Exploratory Phase |
30/05/2024 |
CENSA |
|
Effect of the probiotic supplement EDC-HHA01 (OptiBiotics Plus) in the treatment of Type 2 Diabetes Mellitus. |
30/05/2024 |
HHA |
|
Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC) |
30/04/2018 |
CIM |
|
CENTAURO-4 Study |
30/04/2017 |
CIGB |
|
HEBERBIOVAC HB vaccine to reference material. |
30/04/2017 |
CIGB |
|
Feasibility and Effectiveness - MAP Online Program - Emerging Adults - Phase II |
30/01/2023 |
DIRECCION DE IN... |
|
Bioequivalence of Trienor |
30/01/2018 |
CIDEM |
|
CV638 ability to protect against homologous Vibrio cholerae 3008 virulent strain |
29/12/2016 |
FINLAY |
|
Bioequivalence of Zidovudine |
29/11/2017 |
CIDEM |
|
Nasalferon in ARI |
29/07/2022 |
CIGB |
|
Quality of life and safety of CARMINAL® nutritional supplement in patients with mild or moderate ulcerative colitis |
29/02/2024 |
CATALYSIS |
|
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) |
28/12/2018 |
CIM |
